Ultragenyx Pharmaceutical Inc.
Creatine prodrugs, compositions and methods of use thereof
Last updated:
Abstract:
The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
Status:
Grant
Type:
Utility
Filling date:
3 Dec 2018
Issue date:
17 May 2022